Lymphoma cells

NICE approval for nivolumab provides new treatment for advanced blood cancer

People with an advanced type of blood cancer will benefit from nivolumab on the NHS following approval by NICE.

Read article

Committee meeting 01 200x200

Managing conflicts of interest – making good decisions

NICE is seeking views on a new conflicts of interest policy to ensure its committees’ decisions are fair and unbiased.

Read article

Myeloma cells

NICE approves more tolerable treatment for blood cancer

Around 2,200 patients a year with multiple myeloma are to benefit from a new, tolerable treatment on the NHS following approval by NICE.

Read article

pills capsules various in packaging - 200x200

New improved BNF and BNFC app launched

Following the recent launch by the publishers of the British National Formulary (BNF) and British National Formulary for children (BNFC) of a new, faster, easier to use and access app, NICE has confirmed that its BNF app will be withdrawn later this year.

Read article

Latest news headlines